M
Martin Brown
Guest
On 08/04/2020 20:13, Ricky C wrote:
If it was genuinely shown to work then why not?
It seems to work in vitro but the jury is still out on whether it is
actually effective as a treatment in humans with Covid-19 infection.
Also it may depend critically on hitting the virus early on before it
becomes serious rather than just before the patient is about to expire.
Germany's strong testing regime may be significant in their unusually
low mortality rate when compared to every other country.
It does seem to have some interesting characteristics that mean it is
also used to treat lupus and mediate excessive immune response there:
https://www.hopkinslupus.org/lupus-treatment/lupus-medications/antimalarial-drugs/
However, that is still a long way from saying that it works in this
particular situation. It has to be worth investigating though.
The US president hyping it and causing clueless muppets to die of
overdoes of the stuff is not at all helpful but sadly to be expected.
--
Regards,
Martin Brown
On Wednesday, April 8, 2020 at 11:23:35 AM UTC-4, amdx wrote:
I had some impression that Hydroxychloroqine had immunosuppressive
or anti-inflammatory effects. Which is where part of the breathing
problems arise, from an overreaction, congesting the lungs. I found
several articles saying it is an immune suppressor, so maybe it
works on two fronts.
https://www.ncbi.nlm.nih.gov/pubmed/28302011
"it has been found that Hydroxychloroquine (HCQ) possesses various
immunomodulatory and anti-inflammatory activities."
We already have many, many immune suppressors available for use.
There are drugs specifically used for cytokine storm conditions. Why
would we use another unrelated compound with poorly established
activity in this mode?
If it was genuinely shown to work then why not?
It seems to work in vitro but the jury is still out on whether it is
actually effective as a treatment in humans with Covid-19 infection.
Also it may depend critically on hitting the virus early on before it
becomes serious rather than just before the patient is about to expire.
Germany's strong testing regime may be significant in their unusually
low mortality rate when compared to every other country.
Besides, the last thing you want to do when treating an infection is
to broadly suppress the immune response. That's a great way to kill
a patient.
It does seem to have some interesting characteristics that mean it is
also used to treat lupus and mediate excessive immune response there:
https://www.hopkinslupus.org/lupus-treatment/lupus-medications/antimalarial-drugs/
However, that is still a long way from saying that it works in this
particular situation. It has to be worth investigating though.
The US president hyping it and causing clueless muppets to die of
overdoes of the stuff is not at all helpful but sadly to be expected.
--
Regards,
Martin Brown